Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease-Reference-Cited by-同舟云学术

Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease

Published:2010-01 Issue:1 Volume:89 Page:37-46
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Hot Arnaud,Toh Myew-Ling,Coppéré Brigitte,Perard Laurent,Girard Madoux Marie Hélène,Mausservey Christelle,Desmurs-Clavel Hélène,Ffrench Martine,Ninet Jacques

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference58 articles.

1. Successful treatment of refractory adult onset Still's disease with rituximab.;Ahmadi-Simab;Ann Rheum Dis,2006

2. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease.;Amenomori;Clin Exp Rheumatol,2005

3. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.;Arlet;Ann Rheum Dis,2006

4. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review.;Dhote;Arthritis Rheum,2003

5. Pathogenesis and management of adult-onset Still's disease.;Efthimiou;Semin Arthritis Rheum,2006

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophagocytic lymphohistiocytosis accompanying Still's disease: A case report;Clinical Case Reports;2023-10

2. A Case of Adult-onset Still’s Disease Complicated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage;ODÜ Tıp Dergisi;2023-08-31

3. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS);Annals of the Rheumatic Diseases;2023-07-24

4. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS);Arthritis & Rheumatology;2023-07-24

5. sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study;Blood Advances;2023-03-06